Upregulation of inhibitory signaling receptor programmed death marker-1 (PD-1) in disease evolution from cutaneous lymphoid dyscrasias to mycosis fungoides and Sezary's syndrome-Reference-Cited by-同舟云学术

Upregulation of inhibitory signaling receptor programmed death marker-1 (PD-1) in disease evolution from cutaneous lymphoid dyscrasias to mycosis fungoides and Sezary's syndrome

Published:2017-06 Issue: Volume:28 Page:54-59
ISSN:1092-9134
Container-title:Annals of Diagnostic Pathology
language:en
Short-container-title:Annals of Diagnostic Pathology

Author:

Nguyen Giang Huong,Olson Luke C.,Magro Cynthia M.

Publisher

Elsevier BV

Subject

General Medicine,Pathology and Forensic Medicine

Reference35 articles.

1. Pigmented purpuric dermatosis: classification by phenotypic and molecular profiles;Magro;Am J Clin Pathol,2007

2. Engagement of the PD-1 immunoinhibitory receptor by a novel B7 family member leads to negative regulation of lymphocyte activation;Freeman;J Exp Med,2000

3. PD-1-PD-1 ligand interaction contributes to immunosuppressive microenvironment of Hodgkin lymphoma;Yamamoto;Blood,2008

4. PD-1 and its ligands in tolerance and immunity;Keir;Annu Rev Immunol,2008

5. Involvement of PD-L1 on tumor cells in the escape from host immune system and tumor immunotherapy by PD-L1 blockade;Iwai;Proc Natl Acad Sci U S A,2002

Cited by 20 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Sezary syndrome revealed by PD‐L1 blockade for tumor stage mycosis fungoides;JEADV Clinical Practice;2024-01-24

2. PD-1 Overexpression in Sézary Syndrome Is Epigenetically Regulated;Journal of Investigative Dermatology;2023-12

3. Folliculotropic Mycosis Fungoides Is Associated with Decreased PD1 Staining Compared with Classic Mycosis Fungoides;Dermatopathology;2023-10-23

4. Real-World Clinical Characteristics, Management, and Outcomes of 44 Paediatric Patients with Hypopigmented Mycosis Fungoides;Acta Dermato-Venereologica;2023-08-22

5. Physiopathologie des lymphomes T cutanés épidermotropes (Mycosis fongoïde et syndrome de Sézary);Annales de Dermatologie et de Vénéréologie - FMC;2023-03